His Highness Sheikh Hamdan bin Rashid Al Maktoum, Deputy Ruler of Dubai, Minister of Finance and President of Dubai Health Authority, today officially opened the 24th edition of Dubai International Pharmaceutical and Technology Conference and Exhibition, DUPHAT, at the Dubai International Convention and Exhibition Centre.
Running until 28th February, 2019, DUPHAT brings together leading pharmaceutical experts, industry professionals and senior health officials, with the aim of exploring the latest advances in drug manufacturing as well as discussing the laws and regulations that govern the patenting, testing, safety and efficacy of drugs.
Following the official opening ceremony, Sheikh Hamdan, accompanied by a number of senior health officials, pharmacy experts and industry professionals, toured the exhibition area which occupies an overall space of 21,000 square metres, where they were briefed about the advances taking place in drug manufacturing and learned about the latest technologies and equipment that are fundamentally transforming the pharmaceutical technology industry.
Commenting on this specialised event, Sheikh Hamdan expressed his delight in the great growth and advancements that the exhibition has witnessed over 24 years pointing out that the reason behind this is the UAE’s economic position and the government’s flexible policies in promoting and supporting continuing medical education.
This year, DUPHAT is expected to attract over 27,500 visitors and participants over three days while the conference features the attendance of 130 international speakers, who offer their unique insights on a variety of topics via 143 scientific lectures, 700 poster presentations and 22 dedicated workshops.
Moreover, conference attendees have an opportunity to earn 36.25 CME credit points from Dubai Health Authority and 22 CME points from the Society of Hospital Pharmacists of Australia, SHPA.
Running parallel to the conference, the DUPHAT Tech exhibition features the attendance of 659 participating brands from 75 countries offering exhibiting companies a chance to showcase leading technologies and advances in drug manufacturing. In addition, the exhibition witnesses the presence of two country pavilions comprising leading pharmaceutical brands from India and China.
Dr. Ali Al Sayed Hussain, Chairman, DUPHAT, said, “The UAE has clearly established itself as a regional hub for pharmaceutical companies owing to the governments patient-friendly liberal policies and a quicker drug approval process for licensing and distribution of drugs. Additionally, the UAE’s reputation as a favourable destination for doing business and rising medical expenditures among populations in the region has attracted the leading multinational pharmaceutical companies to consider setting up new manufacturing bases in the UAE.”
DUPHAT is organised annually by INDEX Conferences and Exhibitions – a member of INDEX Holding in strategic partnership with General Directorate of Residency and Foreigners Affairs, GDRFA, Dubai and is supported by Dubai Health Authority, International Society for Pharmacoepidemiology, European Society of Oncology Pharmacy, European Federation for Pharmaceutical science, European society of Clinical pharmacy.